Search clinical trials for: DPP-4 inhibition; Exendin [9-39]

Total 18185 results

Shanghai Zerun Biotechnology Co.,Ltd
Walvax Biotechnology Co., Ltd.

Active, not recruiting

Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9

Cervical Cancer | Papillomavirus Infections | CIN | Genital Wart | VIN

China
Centre Hospitalier Universitaire de la Réunion

Completed

Study of the Impact of a School Program Combining - Promotion of HPV Vaccination and HPV Vaccine Offer in Middle School - on Adherence to HPV Vaccination in Middle School Students (PROM SSCOL)

Papilloma Viral Infection

France
Federico II University

Completed

Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Subjects

Obesity | Nutrition | Mediterranean Diet | Sirtuin 4
University of Maryland, Baltimore

Withdrawn

TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B (BOOST-9)

Hepatitis B

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study of Nonoxynol-9 (N-9) and HIV Infection

HIV Infections

United States
University of Miami
Florida

Completed

Addressing Colorectal Cancer in South Florida Firefighters

Colorectal Cancer | CRC

United States
Loyola University

Recruiting

Community Based DPP Program for Hispanic/Latino Females

Obesity | Pre Diabetes

United States
Bristol-Myers Squibb
Nitto Denko Corporation

Completed

Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)

Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4)

Bulgaria, United States
Bial - Portela C S.A.

Completed

Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients

Parkinson's Disease

Romania, Ukraine
Bial - Portela C S.A.

Completed

Effect of BIA 9-1067 on Rasagiline Pharmacokinetics

Parkinson Disease

France
Bial - Portela C S.A.

Completed

Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 9-1067 on Cardiac Repolarization in Healthy Adult Men and Women

Parkinson Disease

France
Western Institute for Veterans Research
Merck Sharp & Dohme LLC; University of Utah

Recruiting

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Warts

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...

Completed

Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia

Acute Lymphocytic Leukemia | Leukemia, Myelocytic, Acute

United States
Bial - Portela C S.A.

Completed

Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects

Parkinson Disease

United States
Bial - Portela C S.A.

Completed

Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa

Parkinson Disease

Canada
Bial - Portela C S.A.

Completed

Effect of Rasagiline on BIA 9-1067 Pharmacokinetics

Parkinson Disease

France
Bial - Portela C S.A.

Completed

A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067

Parkinson's Disease

Portugal, Romania, Ukraine
Bial - Portela C S.A.

Completed

Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites

Parkinson Disease

Switzerland
Cancer Trials Ireland

Completed

TC Avastin. ICORG 08-10, V6

Breast Cancer

Ireland, Denmark
Wuxi No. 4 People's Hospital

Not yet recruiting

Safety Study of 89Zr-NY001 PET Imaging in Patients

Solid Tumor, Adult

China
Wuxi No. 4 People's Hospital

Completed

18F-FDG PET/CT in the Diagnosis of Tuberculous Pericarditis

Diagnostic Self Evaluation
Ningbo Municipal No.4 Hospital

Completed

Abdomen CT and Open Appendicectomy：New Diagnostic and Surgical Procedures (ACAOA)

Wound Infection | Scar | Complication
Azienda Sanitaria Locale 4, Teramo

Unknown

Evaluation of the Efficacy and Tolerability of Etoricoxib Monotherapy Versus Combination Oxycodone-etoricoxib in Moderate to Severe Pain From Chronic Low Back Pain

Low Back Pain

Italy
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age (QHD04)

Influenza

United States, Canada
Brigham and Women's Hospital

Completed

Replication of the EMPAREG Diabetes Trial in Healthcare Claims

Diabetes

United States
Naturex SA
Biofortis Mérieux NutriSciences

Completed

Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts (KING)

Healthy Subject

France
Biogen

Completed

One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study (PERFUSE)

Arthritis, Rheumatoid | Crohn's Disease | Arthritis, Psoriatic | Colitis, Ulcerative | Spondylitis, Ankylosing

France
Piazza della Vittoria 14 Studio Medico - Ginecologia...

Completed

Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed

COVID-19 | Infertility, Female | IVF | ART

Italy
National Institute of Diabetes and Digestive and...

Not yet recruiting

Pilot Study of Isocaloric Time Restricted Eating on Ketone Metabolism and Immunoregulation

Obesity | Body Weight

United States
Brigham and Women's Hospital

Completed

Replication of the DECLARE Diabetes Trial in Healthcare Claims

Diabetes

United States
Eisai Co., Ltd.

Recruiting

A Study of E7130 in Participants With Solid Tumors

Solid Tumors

Japan
Ra Pharmaceuticals, Inc.

Terminated

Extension Study of RA101495 for Patients With PNH Who Have Completed a Zilucoplan (RA101495) Clinical Study

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United States, Australia, Canada, Finland, Germany, Hungary, New Zealand, United Kingdom
Evotec Neurosciences GmbH
PRA Health Sciences; Clinpharm International Management Holding GmbH

Completed

Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation.

Smoking Cessation

Germany
Philips Healthcare

Completed

Validation of Medication Non-adherence Model (UK)

Diabetes Mellitus | Chronic Obstructive Pulmonary Disease | Chronic Illness | Primary Care | Medication Management at Home

United Kingdom
The Hong Kong Polytechnic University
Menicon Co., Ltd.

Completed

Discontinuation of Lens Wear in New Ortho-k Children (DOEE2) (DOEE2)

Myopia

China
Xiang Xie
Xinjiang Medical University

Not yet recruiting

Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer

Cancer | Atherosclerotic Cardiovascular Disease | ASCVD | Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
Sarepta Therapeutics, Inc.

Active, not recruiting

A Study to Compare Safety and Efficacy of a High Dose of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)

Muscular Dystrophy, Duchenne

United States, Korea, Republic of, India, Slovenia, Turkey, United Kingdom, Germany, Switzerland, Spain, Czechia, France, Serbia, Taiwan, Netherlands, Mexico, Colombia, Denmark, New Zealand, Norway, Greece, Hungary, Ireland, Italy, Jo... and more
Corcept Therapeutics

Enrolling by invitation

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Cushing Syndrome

United States, Austria, Bulgaria, Germany, Israel, Italy, Netherlands, Romania, Spain, Poland, Canada
Epigenomics, Inc
Emory University; Kaiser Permanente

Withdrawn

Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test

Colorectal Cancer

United States
University Hospital, Basel, Switzerland
University Hospital Inselspital, Berne; Desirée and Niels Yde's Foundation,...

Completed

New Imaging Procedure for the Localisation of Insulinoma

Endogenous Hyperinsulinaemic Hypoglycaemia

Switzerland
University of Alabama at Birmingham
Merck Sharp & Dohme LLC

Completed

Postpartum HPV Vaccination

HPV-Related Malignancy

United States
Hadassah Medical Organization

Completed

Evaluation of the Effectiveness of a Novel Gait Trainer in Increasing the Functionality of Motor Impaired Patients: Pilot Study

To Evaluate Effectiveness of the Gait Trainer in Increasing the Functionality and Spatiotemporal Parameters of Gait of 4 Patients.

Israel
Miquel Angel Pavon Ribas
Catalan Institute of Health; Hospital del Mar

Recruiting

A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) (RIFT-HPV)

Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III) | Human Papillomavirus (HPV) Infections | High-risk HPV | HPV-16/ 18

Spain
AQTIS Medical B.V.

Enrolling by invitation

A Prospective, Multicenter, Post-marketing Clinical Follow-up Research to Evaluate the Long-term Safety of Ellansé-S Dermal Filler Made of PCL Microspheres for the Correction of Moderate-to-severe Nasolabial Folds

Moderate-to-severe Nasolabial Folds (3-4 Level of WSRS Scores) on Both Sides of the Face

China
University Hospital, Montpellier

Terminated

Difficult Intubation in Intensive Care

Difficult Intubation in ICU | Strictly More Than Two Laryngoscopies | Cormack Grade Three/Four

France
University of California, Los Angeles
Patient-Centered Outcomes Research Institute

Completed

Is MyPlate Approach to Helping Overweight Patients Lose Weight More Patient-centered?

Obesity

United States
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetic Ketoacidosis | Lower Extremity Amputation | Urosepsis

Canada
MedSIR
Daiichi Sankyo

Not yet recruiting

T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases (TUXEDO-4)

Breast Cancer | Metastatic Breast Cancer
University of California, San Francisco

Recruiting

Intralesional HPV Vaccine for Condylomata

Warts | Condylomata Acuminata | Human Papilloma Virus | Warts, Genital | Condyloma

United States

Search clinical trials for: DPP-4 inhibition; Exendin [9-39]

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations